THE EFFECT OF SMOKING ON ULCERATIVE COLITIS - A REVIEW ARTICLE
Abstract
Introduction: Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disorder of the colonic mucosa. It affects patients' health and quality of life, and can result in life-threatening complications, such as colon cancer. The aim of the study is to present current knowledge on the impact of cigarette smoking on the onset, course and treatment of ulcerative colitis.
Methodology: The authors conducted a comprehensive search of the PubMed electronic database using the keywords. Duplicate studies were removed, and the remaining articles were assessed based on their title and abstract. A total of 20 studies met the inclusion criteria and were subjected to critical review, assessing the methodological design, sample characteristics, and the type and duration of follow-up of the population groups. The primary research for this article was conducted in July 2025.
Conclusion: Compared with non-smokers, former smokers have a significantly higher risk of developing ulcerative colitis (UC), and this risk may be proportional to cumulative exposure to tobacco smoke. Based on the presented reports, we can conclude that any potential protective effect is small and observed only in men. The study results do not constitute a basis for justifying cigarette smoking. Combined with numerous other publications in various fields of medicine, primarily oncology and cardiovascular disease, this leads to one clear conclusion: it’s best not to start smoking at all.
References
Abraham N., Selby W., et al. Is smoking an indirect risk factor for the development of ulcerative colitis? An age- and sex-matched case-control study. (2003) J Gastroenterol Hepatol Volume 18, 139-146.
Beaugerie L, Massot N, et al. Impact of cessation of smoking on the course of ulcerative colitis. (2001) Am J Gastroenterol. Volume 96(7): 2113-2116. DOI:10.1111/j.1572-0241.2001.03944.x.
Birtwistle J. The role of cigarettes and nicotine in the onset and treatment of ulcerative colitis. (1996) Postgrad. Med. J.; Volume 72: 714–718. DOI: 10.1136/pgmj.72.854.714.
Blackwell J, Saxena S, et al. The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population-based study. (2019) Aliment Pharmacol Ther. Volume 50(5):556-567. DOI:10.1111/apt.15390.
Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. (2004) Best Pract Res Clin Gastroenterol Volume 18: 481-96.
Dias CC, Rodrigues PP, et al. Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies. (2015) J Crohns Colitis. Volume 9(2):156-163. DOI:10.1093/ecco-jcc/jju016.
Harries AD, Baird A, Rhodes J. (1982) Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) Volume 284, 706. DOI:10.1136/bmj.284.6317.706.
Higuchi LM, Khalili H, et al. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. (2012) Am J Gastroenterol. Volume 107(9), 1399-1406. DOI: 10.1038/ajg.2012.196.
Ingram JR, Thomas GA, et al. A randomized trial of nicotine enemas for active ulcerative colitis. (2005) Clin Gastroenterol Hepatol. Volume 3(11):1107-1114. DOI: 10.1016/s1542-3565(05)00849-9.
Lakatos PL, Vegh Z, et al. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. (2013) Inflamm Bowel Dis. Volume 19(5):1010-1017. DOI: 10.1097/MIB.0b013e3182802b3e.
Mahid SS, Minor KS, et al. Smoking and inflammatory bowel disease: a meta-analysis. (2006) Mayo Clin Proc. Volume 81(11):1462-1471. DOI:10.4065/81.11.1462. Erratum in: (2007) Mayo Clin Proc. Volume 82(7): 890.
Nishikawa A, Tanaka K, et al., Japan Ulcerative Colitis Study Group. Active and passive smoking and risk of ulcerative colitis: A case-control study in Japan. (2022) J Gastroenterol Hepatol. Volume 37(4) 653-659. DOI: 10.1111/jgh.15745.
Ordás I., Eckmann L., et al. (2012) Ulcerative colitis. The Lancet, Volume 380, (Issue 9853), 1606–1619. DOI: 10.1016/S0140-6736(12)60150-0.
Park S., Chun J. et al. (2019) Dose–response relationship between cigarette smoking and risk of ulcerative colitis: a nationwide population-based study. J Gastroenterol Volume 54, 881–890. DOI: https://doi.org/10.1007/s00535-019-01589-3.
Pullan RD., Rhodes J., et al. Transdermal nicotine for active ulcerative colitis. (1994) N Engl J Med. Volume 330(12):811-815. DOI:10.1056/NEJM199403243301202.
Reif S, Klein I, et al. Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. (1995) Gastroenterology. Volume 108(6):1683-7. DOI: 10.1016/0016-5085(95)90129-9.
Thomas GA, Rhodes J, et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. (1995) N Engl J Med. Volume 332(15): 988-992. DOI: 10.1056/NEJM199504133321503.
Thomas GA, Rhodes J, et al. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. (1996) Eur J Gastroenterol Hepatol. Volume 8(8):769-776.
Thomas GA, Rhodes J, Ingram JR. Mechanisms of disease: nicotine - a review of its actions in the context of gastrointestinal disease. (2005) Nat Clin Pract Gastroenterol Hepatol Volume 2, 536–544.
Yokoyama Y, Yamakawa T, et al. Current Diagnostic and Therapeutic Approaches to Cytomegalovirus Infections in Ulcerative Colitis Patients Based on Clinical and Basic Research Data. (2020) Int J Mol Sci. Volume 21(7):2438. DOI:10.3390/ijms21072438.
Views:
43
Downloads:
13
Copyright (c) 2025 Kinga Knutelska, Patrycja Jędrzejewska-Rzezak, Monika Czekalska, Natalia Kulicka, Aleksandra Winsyk, Paulina Gajniak, Maciej Karwat, Tytus Tyralik, Klaudia Bilińska, Joanna Węgrzecka
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
